19:50 EDT NRX Pharmaceuticals trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRXP:
- NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Navigating the Minefield: Nrx Pharmaceuticals’ Tightrope Walk Between Safety Regulations and Operational Hazards
- NRX Pharmaceuticals Announces Reverse Stock Split
- NRx Pharmaceuticals sees FY23 EPS (40c), consensus (37c)
- NRx Pharmaceuticals announces 1-for-10 reverse stock split